FIELD: chemistry.
SUBSTANCE: invention relates to novel piperazine derivatives of formula (I) 
, where Q is methyl, benzyl or (1,1'-biphenyl)-3-ylmethyl, and pharmacologically acceptable salts thereof. The invention also relates to a pharmaceutical composition, to a method of preparing pharmaceutical compositions, to use of the compounds, as well as to a method of producing the compounds.
EFFECT: obtaining novel biologically active compounds with partial or complete agonist effect on dopamine D2 and 5-HT1A receptors.
9 cl, 6 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BICYCLO-3,1,1-HEPTANE-SUBSTITUTED BENZIMIDAZOLONE- AND QUINAZOLINONE-DERIVATIVES AS AGONISTS OF HUMAN ORL1 RECEPTORS | 2004 |
|
RU2357964C2 |
| TRANSCUTANEOUS INJECTION OF PIPERAZINYL-2(3H)-BENZOXAZOLOL BY ELECTROPHORESIS | 2005 |
|
RU2371179C2 |
| HEXA- AND OCTAHYDROPYRIDO[1,2-a]PYRAZINE DERIVATIVES WITH NK-ANTAGONIST ACTIVITY | 2004 |
|
RU2349591C2 |
| N-OXIDE AND/OR DI-N-OXIDE DERIVATIVES OF STABILISERS/MODULATORS OF DOPAMINE RECEPTORS, DEMONSTRATING IMPROVED PROFILES OF CARDIO-VASCULAR SIDE EFFECTS | 2008 |
|
RU2470013C2 |
| 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE-METHYL, POLYMORPHOUS FORMS AND METHODS FOR USE THEREOF | 2014 |
|
RU2693833C2 |
| COMPOSITIONS AND METHODS ASSOCIATED THEREWITH | 2017 |
|
RU2764716C2 |
| INHIBITORS OF PHOSPHODIESTERASE 10 ENZYME | 2013 |
|
RU2667058C2 |
| TARGET DRUG WITH NEW COMPOSITIONS, COMBINATIONS AND METHODS | 2018 |
|
RU2760558C2 |
| DERIVATIVES OF PIPERAZINE OXIME POSSESSING ANTAGONISTIC ACTIVITY WITH RESPECT TO NEUROKININE-1 (NK-1) RECEPTOR | 2002 |
|
RU2273639C2 |
| NEW MODULATORS OF CORTICAL DOPAMINERGIC AND GLUTAMATERGIC NEUROTRANSMISSION MEDIATED BY NMDA-RECEPTOR | 2012 |
|
RU2593500C2 |
